Repository logo
 

Analysis of endothelial-to-haematopoietic transition at the single cell level identifies cell cycle regulation as a driver of differentiation

Published version
Peer-reviewed

Change log

Authors

Canu, Giovanni 
Athanasiadis, Emmanouil 
Grandy, Rodrigo A. 
Garcia-Bernardo, Jose 
Strzelecka, Paulina M. 

Abstract

Abstract: Background: Haematopoietic stem cells (HSCs) first arise during development in the aorta-gonad-mesonephros (AGM) region of the embryo from a population of haemogenic endothelial cells which undergo endothelial-to-haematopoietic transition (EHT). Despite the progress achieved in recent years, the molecular mechanisms driving EHT are still poorly understood, especially in human where the AGM region is not easily accessible. Results: In this study, we take advantage of a human pluripotent stem cell (hPSC) differentiation system and single-cell transcriptomics to recapitulate EHT in vitro and uncover mechanisms by which the haemogenic endothelium generates early haematopoietic cells. We show that most of the endothelial cells reside in a quiescent state and progress to the haematopoietic fate within a defined time window, within which they need to re-enter into the cell cycle. If cell cycle is blocked, haemogenic endothelial cells lose their EHT potential and adopt a non-haemogenic identity. Furthermore, we demonstrate that CDK4/6 and CDK1 play a key role not only in the transition but also in allowing haematopoietic progenitors to establish their full differentiation potential. Conclusion: We propose a direct link between the molecular machineries that control cell cycle progression and EHT.

Description

Funder: INTENS EU fp8 consortium


Funder: ERC advanced grant New-Chol

Keywords

Research

Journal Title

Genome Biology

Conference Name

Journal ISSN

1474-760X

Volume Title

21

Publisher

BioMed Central
Sponsorship
British Heart Foundation (GB) (PhD Studentship)
Cancer Research UK (C45041/A14953)
European Research Council () (677501)
Wellcome Trust and MRC (Core support grant to Cambridge Stem Cell Institute)